Pediatr. praxi. 2024;25(6):398-400 | DOI: 10.36290/ped.2024.075

Juvenile xanthogranuloma in newborn and infant age

MUDr. Jiří Bufka1, 2, MUDr. Ilona Ngoc Šleisová3, MUDr. Magdalena Daumová, Ph.D.4
1 Univerzita Karlova, Lékařská fakulta v Plzni, Dětská klinika, Fakultní nemocnice Plzeň
2 Oddělení revmatologie dětí a dospělých, Fakultní nemocnice Motol
3 Univerzita Karlova, Lékařská fakulta v Plzni, Neonatologické oddělení, Fakultní nemocnice Plzeň
4 Univerzita Karlova, Lékařská fakulta v Plzni, Šiklův ústav patologie, Fakultní nemocnice Plzeň

Juvenile xanthogranuloma, benign, proliferative disorder, most common of the non-Langerhans cell histiocytosis, mentioned in the article with regard to its histopathological background, clinical evaluation, diagnostic, differential diagnosis and treatment.

Keywords: JXG, histopathogenesis, clinical evaluation, differential diagnosis, treatment.

Accepted: December 10, 2024; Published: December 31, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bufka J, Šleisová IN, Daumová M. Juvenile xanthogranuloma in newborn and infant age. Pediatr. praxi. 2024;25(6):398-400. doi: 10.36290/ped.2024.075.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • PDF will be unlocked 31.12.2025

    References

    1. So N, Liu R, Hogeling M. Juvenile xanthogranulomas: Examining single, multiple, and extracutaneous presentations. Pediatr Dermatol. 2020;37:637. Go to original source... Go to PubMed...
    2. Paxton CN, O'Malley DP, Bellizzi AM, et al. Genetic evaluation of juvenile xanthogranuloma: genomic abnormalities are uncommon in solitary lesions, advanced cases may show more complexity. Mod Pathol. 2017;30:1234. Go to original source... Go to PubMed...
    3. Diamond EL, Durham BH, Haroche J, et al. Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms. Can­cer Discov. 2016;6:154. Go to original source... Go to PubMed...
    4. Salari B, Dehner LP. Juvenile Xanthogranuloma: A Comparative Immunohistochemical Study of Factor XIIIa, CD11c, and CD4. Am J Dermatopathol. 2022;44:493. Go to original source... Go to PubMed...
    5. Kundak S, Çakir Y. Juvenile xanthogranuloma: retrospective analysis of 44 pediatric cases (single tertiary care center experience). Int J Dermatol. 2021;60:564. Go to original source... Go to PubMed...
    6. So N, Liu R, Hogeling M. Juvenile xanthogranulomas: Examining single, multiple, and extracutaneous presentations. Pediatr Dermatol. 2020;37:637. Go to original source... Go to PubMed...
    7. Dehner LP. Juvenile xanthogranulomas in the first two decades of life: a clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations. Am J Surg Pathol. 2003;27:579. Go to original source... Go to PubMed...
    8. Ferrari F, Masurel A, Olivier-Faivre L, et al. Juvenile xanthogranuloma and nevus anemicus in the diagnosis of neurofibromatosis type 1. JAMA Dermatol. 2014;150:42. Go to original source... Go to PubMed...
    9. Miraglia E, Laghi A, Moramarco A, et al. Juvenile xanthogranuloma in neurofibromatosis type 1. Prevalence and possible correlation with lymphoproliferative diseases: experience of a single center and review of the literature. Clin Ter. 2022;173:353.
    10. Fenot M, Stalder JF, Barbarot S. Juvenile xanthogranulomas are highly prevalent but transient in young children with neurofibromatosis type 1. J Am Acad Dermatol. 2014;71:389. Go to original source... Go to PubMed...
    11. Liy-Wong C, Mohammed J, Carleton A, et al. The relationship between neurofibromatosis type 1, juvenile xanthogranuloma, and malignancy: A retrospective case-control study. J Am Acad Dermatol. 2017;76:1084. Go to original source... Go to PubMed...
    12. Xu J, Ma L. Dermoscopic Patterns in Juvenile Xanthogranuloma Based on the Histological Classification. Front Med (Lausanne). 2021 Jan 13;7:618946. doi: 10.3389/fmed.2020.618946. PMID: 33521026; PMCID: PMC7838354. Go to original source... Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.